Bankrupt Pharma Co. Impel Gets OK For $17.5M Sale
By Ben Zigterman · February 1, 2024, 7:45 PM EST
Migraine-drug maker Impel Pharmaceuticals can proceed with its sale to JN Bidco LLC, which had made a $17.5 million stalking horse bid, U.S. Bankruptcy Judge Stacey G. Jernigan said at a...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login